Artelo Biosciences (ARTL) Earnings Date & Reports

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ARTL is expected to report earnings to fall 88.89% to -12 cents per share on May 08

Artelo Biosciences ARTL Stock Earnings Reports

Q1'25

Est.

$-0.13

Q4'24

Missed

by $0.73

Q3'24

Beat

by $0.44

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.13

The last earnings report on March 03 showed earnings per share of -116 cents, missing the estimate of -43 cents. With 27.08K shares outstanding, the current market capitalization sits at 3.31M.

View a ticker or compare two or three

Compare

ARTL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ARTL
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

505 Lomas Santa Fe

Phone

+1 858 925-7049

Employees

Web

https://www.artelobio.com